-
admin
Posts
MEGA MATRIX CORP. Announces Second Quarter 2024 Financial Results
PALO ALTO, Calif., Aug. 15, 2024 /PRNewswire/ — Mega Matrix Corp. (“MPU” or the “Company”) (NYSE American: MPU), today announced financial results for its second...
CHIVAS REGAL SCORES BIG WITH MULTI-YEAR GLOBAL ARSENAL PARTNERSHIP
The iconic blended Scotch whisky will become the club’s Official Whisky Partner celebrating their shared ambition for collective success ahead of the new season To celebrate...
LGI Homes Opens Master-Planned Community in the Portland Market
VANCOUVER, Wash., Aug. 14, 2024 (GLOBE NEWSWIRE) — LGI Homes, Inc. (NASDAQ:LGIH) today announced the grand opening of Beverly, a new community located 30 minutes...
The Impact of Convenience in the Consumer Goods and Services Sector: Case Studies of BuzzBallz, Cathay Pacific, MTR, Pop-Tarts Bites and Suzuki Shuzoten
Dublin, Aug. 14, 2024 (GLOBE NEWSWIRE) — The “Megatrends: Convenience – Impact on Consumer Goods and Services Categories” report has been added to ResearchAndMarkets.com’s offering....
Victoria’s Secret & Co. Appoints Hillary Super Chief Executive Officer
Seasoned executive and proven merchant operator to take brands to the next level Preliminary Q2 results at the top end or above company guidance for...
Invivyd Reports Second Quarter 2024 Financial Results and Recent Business Highlights
PEMGARDA™ launched commercially in Q2 2024 with $2.3 million of net product revenue Notable acceleration of commercial results in early Q3 2024, with the anticipated...
Kent Kresa to Retire from MannKind’s Board of Directors; Steven B. Binder to be Appointed to the Board
DANBURY, Conn. and WESTLAKE VILLAGE, Calif., Aug. 14, 2024 (GLOBE NEWSWIRE) — MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of...
Monopar Announces Initial Data for First Patient Dosed in Radiopharma Phase 1 Clinical Trial of MNPR-101-Zr
WILMETTE, Ill., Aug. 14, 2024 (GLOBE NEWSWIRE) — Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage radiopharma company focused on developing innovative treatments for cancer patients,...
IMUNON Reports Second Quarter 2024 Financial Results and Provides a Business Update
Conference Call Begins Today at 11:00 a.m. Eastern Time LAWRENCEVILLE, N.J., Aug. 14, 2024 (GLOBE NEWSWIRE) — IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage company in...
VYNE Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
Initiated Phase 2b trial of VYN201 in nonsegmental vitiligo, with top-line results expected in mid-2025 Phase 1a SAD/MAD trial of VYN202 progressing, with data from...